Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome

NCT02411110 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02411110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02411110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis/Bladder Pain Syndrome
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
May 21, 2015
Completion date
January 9, 2017
Enrollment
131 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

cystitis, interstitial, painful bladder syndrome